Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
MDGL holding history
Madrigal Pharmaceuticals, Inc. in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MDGL overviewAll 13F holders of MDGLFull Q2 2026 holdings
- Shares (Q2 2026)
- 281,500
- Value
- $151.2M
- % of portfolio
- 0.4%
- Quarters held
- 11
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 281,500 | $151.2M | 0.4% | +38,774+16.0% | Added | Holders |
| Q1 2026 | 242,726 | $127.1M | 0.4% | −2,070−0.8% | Reduced | Holders |
| Q4 2025 | 244,796 | $142.6M | 0.4% | +142,653+139.7% | Added | Holders |
| Q3 2025 | 102,143 | $46.8M | 0.1% | +17,926+21.3% | Added | Holders |
| Q2 2025 | 84,217 | $25.5M | 0.1% | −33,807−28.6% | Reduced | Holders |
| Q1 2025 | 118,024 | $39.1M | 0.1% | +69,107+141.3% | Added | Holders |
| Q4 2024 | 48,917 | $15.1M | <0.1% | +48,917 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −97,103−100.0% | Sold out | Holders |
| Q1 2024 | 97,103 | $25.9M | 0.1% | +97,103 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −67,918−100.0% | Sold out | Holders |
| Q2 2023 | 67,918 | $15.7M | 0.1% | −107−0.2% | Reduced | Holders |
| Q1 2023 | 68,025 | $16.5M | 0.1% | −110,493−61.9% | Reduced | Holders |
| Q4 2022 | 178,518 | $51.8M | 0.2% | +178,518 | New | Holders |